These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 15368364)

  • 1. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPK inhibition by 1alpha,25(OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src.
    Rossi AM; Capiati DA; Picotto G; Benassati S; Boland RL
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):287-90. PubMed ID: 15225787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAP kinases p38 and JNK are activated by the steroid hormone 1alpha,25(OH)2-vitamin D3 in the C2C12 muscle cell line.
    Buitrago CG; Ronda AC; de Boland AR; Boland R
    J Cell Biochem; 2006 Mar; 97(4):698-708. PubMed ID: 16215981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related alteration of 1alpha,25(OH)2-vitamin D3-dependent activation of p38 MAPK in rat intestinal cells.
    Pardo VG; Facchinetti MM; Curino A; Boland R; de Boland AR
    Biogerontology; 2007 Feb; 8(1):13-24. PubMed ID: 16855859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells.
    Capiati D; Benassati S; Boland RL
    J Cell Biochem; 2002; 86(1):128-35. PubMed ID: 12112023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
    Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
    J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of MAPK ERK1 and ERK2 in VDR-positive and -negative breast cancer cell lines.
    Cordes T; Diesing D; Becker S; Diedrich K; Reichrath J; Friedrich M
    Anticancer Res; 2006; 26(4A):2749-53. PubMed ID: 16886687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1,25(OH)(2)D(3).
    Buitrago C; Vazquez G; De Boland AR; Boland R
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1150-6. PubMed ID: 11741312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25(OH)(2)-Vitamin D(3) stimulates intestinal cell p38 MAPK activity and increases c-Fos expression.
    Pardo VG; Boland R; de Boland AR
    Int J Biochem Cell Biol; 2006; 38(7):1181-90. PubMed ID: 16483831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells.
    Marcinkowska E; Wiedłocha A; Radzikowski C
    Biochem Biophys Res Commun; 1997 Dec; 241(2):419-26. PubMed ID: 9425286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pp60c-src mediates ERK activation/nuclear localization and PAI-1 gene expression in response to cellular deformation.
    Samarakoon R; Higgins PJ
    J Cell Physiol; 2003 Jun; 195(3):411-20. PubMed ID: 12704650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
    Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
    J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.